Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Manisha H. Shah, Whitney Goldner, Al B. Benson, +33

Journal of the National Comprehensive Cancer Network

Surgical OncologyAdrenal TumorsPathologyGliomaTumor Biology +17

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Osama E. Rahma, Greg Yothers, Theodore S. Hong, +20

JAMA Oncology

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

Namrata Vijayvergia, Patrick M. Boland, Elizabeth A. Handorf, +7

British Journal of Cancer

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

Namrata Vijayvergia, Arvind Dasari, Mengying Deng, +12

British Journal of Cancer

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

Jennifer A. Chan, Susan M. Geyer, Tyler Zemla, +21

New England Journal of Medicine

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites

Wafik S. El‐Deiry, Namrata Vijayvergia, Joanne Xiu, +6

Cancer Biology & Therapy

PathologyCancer BiologyTumor BiologyMolecular ProfilingOncology +14

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Jaydira Del Rivero, Kimberly Perez, Erin B. Kennedy, +23

Journal of Clinical Oncology

Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms

Jennifer R. Eads, Þorvarður R. Hálfdánarson, Tim Asmis, +14

Endocrine Related Cancer

Oncologic ImagingGynecologyPathologyHigh-grade Neuroendocrine NeoplasmsGlioma +14

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

Thomas J. George, Greg Yothers, Osama E. Rahma, +16

Journal of Clinical Oncology

Surgical OncologyCancer ManagementSecondary EpsSurgeryMss Larc +18

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations

Safoora Deihimi, Avital Lev, Michael Slifker, +11

Oncotarget